全文获取类型
收费全文 | 5266篇 |
免费 | 395篇 |
国内免费 | 254篇 |
专业分类
5915篇 |
出版年
2024年 | 8篇 |
2023年 | 71篇 |
2022年 | 125篇 |
2021年 | 231篇 |
2020年 | 178篇 |
2019年 | 215篇 |
2018年 | 195篇 |
2017年 | 176篇 |
2016年 | 280篇 |
2015年 | 320篇 |
2014年 | 358篇 |
2013年 | 415篇 |
2012年 | 478篇 |
2011年 | 422篇 |
2010年 | 251篇 |
2009年 | 201篇 |
2008年 | 284篇 |
2007年 | 226篇 |
2006年 | 196篇 |
2005年 | 172篇 |
2004年 | 184篇 |
2003年 | 133篇 |
2002年 | 141篇 |
2001年 | 82篇 |
2000年 | 49篇 |
1999年 | 73篇 |
1998年 | 51篇 |
1997年 | 55篇 |
1996年 | 38篇 |
1995年 | 29篇 |
1994年 | 33篇 |
1993年 | 22篇 |
1992年 | 33篇 |
1991年 | 12篇 |
1990年 | 12篇 |
1989年 | 15篇 |
1988年 | 15篇 |
1987年 | 13篇 |
1986年 | 11篇 |
1985年 | 11篇 |
1984年 | 12篇 |
1983年 | 20篇 |
1980年 | 5篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 4篇 |
1975年 | 8篇 |
1974年 | 7篇 |
1973年 | 6篇 |
排序方式: 共有5915条查询结果,搜索用时 15 毫秒
141.
Chi Song Gary K. Chen Robert C. Millikan Christine B. Ambrosone Esther M. John Leslie Bernstein Wei Zheng Jennifer J. Hu Regina G. Ziegler Sarah Nyante Elisa V. Bandera Sue A. Ingles Michael F. Press Sandra L. Deming Jorge L. Rodriguez-Gil Stephen J. Chanock Peggy Wan Xin Sheng Loreall C. Pooler David J. Van Den Berg Loic Le Marchand Laurence N. Kolonel Brian E. Henderson Chris A. Haiman Daniel O. Stram 《PloS one》2013,8(2)
Genome-wide association studies (GWAS) simultaneously investigating hundreds of thousands of single nucleotide polymorphisms (SNP) have become a powerful tool in the investigation of new disease susceptibility loci. Haplotypes are sometimes thought to be superior to SNPs and are promising in genetic association analyses. The application of genome-wide haplotype analysis, however, is hindered by the complexity of haplotypes themselves and sophistication in computation. We systematically analyzed the haplotype effects for breast cancer risk among 5,761 African American women (3,016 cases and 2,745 controls) using a sliding window approach on the genome-wide scale. Three regions on chromosomes 1, 4 and 18 exhibited moderate haplotype effects. Furthermore, among 21 breast cancer susceptibility loci previously established in European populations, 10p15 and 14q24 are likely to harbor novel haplotype effects. We also proposed a heuristic of determining the significance level and the effective number of independent tests by the permutation analysis on chromosome 22 data. It suggests that the effective number was approximately half of the total (7,794 out of 15,645), thus the half number could serve as a quick reference to evaluating genome-wide significance if a similar sliding window approach of haplotype analysis is adopted in similar populations using similar genotype density. 相似文献
142.
143.
Mechanisms governing the metastasis of endometrial carcinoma (EC) are poorly defined. Recent data support a role for the cell surface receptor tyrosine kinase TrkB in the progression of several human tumors. Here we present evidence for a direct role of TrkB in human EC. Immunohistochemical analysis revealed that TrkB and its secreted ligand, brain-derived neurotrophic factor (BDNF), are more highly expressed in EC than in normal endometrium. High TrkB levels correlated with lymph node metastasis (p<0.05) and lymphovascular space involvement (p<0.05) in EC. Depletion of TrkB by stable shRNA-mediated knockdown decreased the migratory and invasive capacity of cancer cell lines in vitro and resulted in anoikis in suspended cells. Conversely, exogenous expression of TrkB increased cell migration and invasion and promoted anoikis resistance in suspension culture. Furthermore, over-expression of TrkB or stimulation by BDNF resulted in altered the expression of molecular mediators of the epithelial-to-mesenchymal transition (EMT). RNA interference (RNAi)-mediated depletion of the downstream regulator, Twist, blocked TrkB-induced EMT-like transformation. The use of in vivo models revealed decreased peritoneal dissemination in TrkB-depleted EC cells. Additionally, TrkB-depleted EC cells underwent mesenchymal-to-epithelial transition and anoikis in vivo. Our data support a novel function for TrkB in promoting EMT and resistance to anoikis. Thus, TrkB may constitute a potential therapeutic target in human EC. 相似文献
144.
145.
Wan Yingling Zhang Min Hong Aiying Lan Xinyu Yang Huiyan Liu Yan 《Plant molecular biology》2020,102(3):239-252
Plant Molecular Biology - Lack of structural components results in inflorescence stem bending. Differentially expressed genes involved in lignin and hemicellulose biosynthesis are vital; genes... 相似文献
146.
Li Yingxue Xu Ping Wan Zhenzhou Du Hong Jin Xia Zhang Chiyu 《Molecular biology reports》2020,47(10):7341-7348
Molecular Biology Reports - Simple, multiplex qPCR methods are advantages for rapid molecular diagnosis of multiple antibiotics-resistant genes simultaneously. However, the number of genes can be... 相似文献
147.
Lu Haotian Shi Chunying Wang Shuang Yang Chaochao Wan Xueqi Luo Yunzhe Tian Le Li Ling 《Molecular biology reports》2020,47(10):7831-7842
Molecular Biology Reports - Non-SMC condensin I complex subunit H (NCAPH) is a structural component of chromosomes during mitosis, which up-regulates in various cancers. However, the role of NCAPH... 相似文献
148.
Chen Jiajia Yang Saishuai Wu Chunshuai Cui Zhiming Wan Yangyang Xu Guanhua Bao Guofeng Zhang Jinlong Chen Chu Song Dianwen 《Neurochemical research》2020,45(10):2302-2311
Neurochemical Research - Spinal cord injury (SCI) is one of the diseases with high probability of causing disability in human beings, and there is no reliable treatment at present. Neuronal... 相似文献
149.
150.
Jun Lei Hongjian Wang Daoming Zhu Yibin Wan Lei Yin 《Journal of cellular physiology》2020,235(5):4814-4823
CD8+ T cells play a vital role in cancer immunotherapy and can be shaped by metabolism. Avasimibe is an acyl coenzyme A-cholesterol acyltransferase (ACAT) inhibitor, which has been clinically verified safe in other phase Ⅲ clinical trials. It can potentiate the killing function of CD8+ T cells by modulating cholesterol metabolism. Doxorubicin (DOX) is an anticancer drug widely used in many cancers to induce tumor cell apoptosis. Unfortunately, DOX also can induce toxic and side effects in many organs, compromising its usage and efficacy. Herein, we report the combinational usage of avasimibe and a safe pH sensitive nano-drug delivery system composing of DOX and metal–organic frameworks nanoparticles (MNPs). Our findings demonstrated that DOX–MNPs treatment inhibited tumor growth with good safety profile and avasimibe treatment combined DOX–MNPs treatment exhibited a better efficacy than monotherapies in 4T1 breast cancer therapy. 相似文献